BIVV

Bioverativ Inc

A biotechnology company that made therapies for hemophilia and other rare blood disorders, selling medicines like Alprolix and Eloctate that help people with the bleeding condition. It was spun off from Biogen in 2017 and acquired by Sanofi in 2018. Its name blends "Bio" from its Biogen roots with a play on "veracity," meaning truth.